![Mark Beveridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Beveridge
Direttore Finanziario/CFO presso
MOBERG PHARMA AB
Profilo
Mark Beveridge currently works at Biosergen AB, as Chief Financial Officer from 2025 and Moberg Pharma AB, as Vice President-Finance from 2015.
Mr. Beveridge also formerly worked at OncoZenge AB, as Chief Financial Officer.
Mr. Beveridge received his undergraduate degree from the University of Western Sydney.
Posizioni attive di Mark Beveridge
| Società | Posizione | Inizio |
|---|---|---|
| MOBERG PHARMA AB | Direttore Finanziario/CFO | 01/01/2015 |
| BIOSERGEN AB | Direttore Finanziario/CFO | 24/07/2025 |
Precedenti posizioni note di Mark Beveridge
| Società | Posizione | Fine |
|---|---|---|
| ONCOZENGE AB | Direttore Finanziario/CFO | - |
Formazione di Mark Beveridge
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
47
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Western Sydney
 University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
OncoZenge AB
 OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
